173 related articles for article (PubMed ID: 6941955)
21. Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.
Tamaoki T; Kasai M; Shirahata K; Ohkubo S; Morimoto M; Mineura K; Ishii S; Tomita F
J Antibiot (Tokyo); 1980 Sep; 33(9):946-50. PubMed ID: 6160139
[TBL] [Abstract][Full Text] [Related]
22. Anthracyclines--modern tumour-inhibiting agents.
Strauss DG
Folia Microbiol (Praha); 1978; 23(2):152-61. PubMed ID: 348587
[No Abstract] [Full Text] [Related]
23. [Leukaemomycin-blocked mutants of Streptomyces griseus and their pigments. III. 11-Desoxydaunomycinone derivatives from the mutant ZIMET 43699/G44].
Wagner C; Eckardt K; Tresselt D; Ihn W; Schumann G; Fleck WF
J Basic Microbiol; 1985; 25(10):687-93. PubMed ID: 3937895
[TBL] [Abstract][Full Text] [Related]
24. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
[TBL] [Abstract][Full Text] [Related]
25. Identification of the anthracycline antibiotic 4-O-(beta-D-glucopyranuronosyl)-epsilon-rhodomycinone, produced by Streptomyces ruber JCM3131, as an up-regulator of MHC class-I molecules in B16/BL6 cells.
Komatsu Y; Takahashi O; Hayashi H
J Antibiot (Tokyo); 1998 Jan; 51(1):85-8. PubMed ID: 9531993
[No Abstract] [Full Text] [Related]
26. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
[TBL] [Abstract][Full Text] [Related]
27. Steffimycin C, a new member of the steffimycin anthracyclines. Isolation and structural characterization.
Brodasky TF; Mizsak S; Hoffstetter JR
J Antibiot (Tokyo); 1985 Jul; 38(7):849-55. PubMed ID: 3839781
[TBL] [Abstract][Full Text] [Related]
28. Structural studies on rhodilunancins A and B.
Li M; Chen YL
J Antibiot (Tokyo); 1986 Mar; 39(3):430-6. PubMed ID: 3700244
[TBL] [Abstract][Full Text] [Related]
29. Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties.
Omura S; Imamura N; Oiwa R; Kuga H; Iwata R; Masuma R; Iwai Y
J Antibiot (Tokyo); 1986 Oct; 39(10):1407-12. PubMed ID: 3781911
[TBL] [Abstract][Full Text] [Related]
30. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
[TBL] [Abstract][Full Text] [Related]
31. Macrolide antibiotics M-4365 produced by Micromonospora. I. Taxonomy, production, isolation, characterization and properties.
Furumai T; Maezawa I; Matsuzawa N; Yano S; Yamaguchi T
J Antibiot (Tokyo); 1977 Jun; 30(6):443-9. PubMed ID: 885804
[TBL] [Abstract][Full Text] [Related]
32. New anthracycline antibiotics produced by interspecific recombinants of streptomycetes. III. Isolation and structure of iremycin.
Ihn W; Schlegel B; Fleck WF; Sedmera P
J Antibiot (Tokyo); 1980 Dec; 33(12):1457-61. PubMed ID: 7251489
[TBL] [Abstract][Full Text] [Related]
33. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
[TBL] [Abstract][Full Text] [Related]
34. Tetrocarcins, novel antitumor antibiotics. I. Producing organism, fermentation and antimicrobial activity.
Tomita F; Tamaoki T
J Antibiot (Tokyo); 1980 Sep; 33(9):940-5. PubMed ID: 6893706
[TBL] [Abstract][Full Text] [Related]
35. Anthracycline antibiotic pharmacology and metabolism.
Bachur NR
Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
[TBL] [Abstract][Full Text] [Related]
36. Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.
Shimosaka A; Kawai H; Hayakawa Y; Komeshima N; Nakagawa M; Seto H; Otake N
J Antibiot (Tokyo); 1987 Sep; 40(9):1283-91. PubMed ID: 3479414
[TBL] [Abstract][Full Text] [Related]
37. Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.
Bush JA; Bradner WT; Tomita K
J Antibiot (Tokyo); 1982 Sep; 35(9):1174-83. PubMed ID: 6754675
[TBL] [Abstract][Full Text] [Related]
38. Biologic activity of adriamycin (NSC-123127) in microbial systems.
Pittillo RF; Woolley C
Cancer Chemother Rep; 1971 Jun; 55(3):221-7. PubMed ID: 5000531
[No Abstract] [Full Text] [Related]
39. Synthesis of 2'-deoxy-L-fucopyranosylcarminomycinone and -epsilon-pyrromycinone as well as 2'-deoxy-D-erythro-pentopyranosyldaunomycinone, -carminomycinone, and -epsilon-pyrromycinone.
El Khadem HS; Swartz DL
J Med Chem; 1981 Jan; 24(1):112-5. PubMed ID: 7205866
[TBL] [Abstract][Full Text] [Related]
40. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
